Epidermolysis bullosa. I. Molecular genetics of the junctional and hemidesmosomal variants
- PMID: 16473856
- PMCID: PMC2564586
- DOI: 10.1136/jmg.2005.039685
Epidermolysis bullosa. I. Molecular genetics of the junctional and hemidesmosomal variants
Abstract
Introduction: Epidermolysis bullosa (EB), a group of autosomal heritable blistering diseases, is characterised by extensive phenotypic variability with considerable morbidity and mortality. EB is classified into distinct subtypes depending on the location of blistering within the cutaneous dermoepidermal basement membrane zone. Ten genes are known to harbour mutations in the major types of EB, and the level of expression of these genes within the cutaneous basement membrane zone and in extracutaneous tissues, as well as the types and combinations of the mutations, explain in general terms the phenotypic variability.
Methods: The DebRA Molecular Diagnostics Laboratory, established in 1996 and supported in part by the patient advocacy organisation DebRA of America, has analysed over 1000 families with different forms of EB.
Results: In total, 265 cases were submitted with the preliminary diagnosis of junctional or hemidesmosomal forms of EB. We found 393 mutant alleles in seven different genes, with 173 of the mutations being distinct and 71 previously unpublished.
Discussion: These findings attest to the clinical and molecular heterogeneity of the junctional and hemidesmosomal subtypes of EB. The results also reveal exceptions to the general rules on genotype-phenotype correlations, unusual phenotypes, and surprising genetics. Collectively, mutation analysis in different forms of EB provides the basis for improved classification with prognostic implications and for prenatal and preimplantation diagnosis in families at risk for recurrence of EB.
Conflict of interest statement
Competing interests: there are no competing interests.
Similar articles
-
Mutation analysis and molecular genetics of epidermolysis bullosa.Matrix Biol. 1999 Feb;18(1):29-42. doi: 10.1016/s0945-053x(98)00005-5. Matrix Biol. 1999. PMID: 10367729 Review.
-
Progress in epidermolysis bullosa: genetic classification and clinical implications.Am J Med Genet C Semin Med Genet. 2004 Nov 15;131C(1):61-74. doi: 10.1002/ajmg.c.30035. Am J Med Genet C Semin Med Genet. 2004. PMID: 15468152 Review.
-
Hemidesmosomal variants of epidermolysis bullosa. Mutations in the alpha6beta4 integrin and the 180-kD bullous pemphigoid antigen/type XVII collagen genes.Exp Dermatol. 1998 Apr-Jun;7(2-3):46-64. doi: 10.1111/j.1600-0625.1998.tb00304.x. Exp Dermatol. 1998. PMID: 9583744 Review.
-
Next generation sequencing identifies double homozygous mutations in two distinct genes (EXPH5 and COL17A1) in a patient with concomitant simplex and junctional epidermolysis bullosa.Hum Mutat. 2018 Oct;39(10):1349-1354. doi: 10.1002/humu.23592. Epub 2018 Aug 3. Hum Mutat. 2018. PMID: 30016581
-
Molecular basis of the dystrophic and junctional forms of epidermolysis bullosa: mutations in the type VII collagen and kalinin (laminin 5) genes.J Invest Dermatol. 1994 Nov;103(5 Suppl):39S-46S. doi: 10.1111/1523-1747.ep12398967. J Invest Dermatol. 1994. PMID: 7963683 Review.
Cited by
-
Epidermolysis bullosa in Danish Hereford calves is caused by a deletion in LAMC2 gene.BMC Vet Res. 2015 Feb 7;11:23. doi: 10.1186/s12917-015-0334-8. BMC Vet Res. 2015. PMID: 25888738 Free PMC article.
-
Protein therapeutics for junctional epidermolysis bullosa: incorporation of recombinant beta3 chain into laminin 332 in beta3-/- keratinocytes in vitro.J Invest Dermatol. 2008 Jun;128(6):1476-86. doi: 10.1038/sj.jid.5701197. Epub 2007 Dec 13. J Invest Dermatol. 2008. PMID: 18079746 Free PMC article.
-
Oral manifestations in the epidermolysis bullosa spectrum.Dermatol Clin. 2010 Jan;28(1):159-64. doi: 10.1016/j.det.2009.10.022. Dermatol Clin. 2010. PMID: 19945630 Free PMC article. Review.
-
Clinical management for epidermolysis bullosa dystrophica.J Appl Oral Sci. 2008 Jan-Feb;16(1):81-5. doi: 10.1590/s1678-77572008000100016. J Appl Oral Sci. 2008. PMID: 19089295 Free PMC article.
-
Skin Microbial Composition and Genetic Mutation Analysis in Precision Medicine for Epidermolysis Bullosa.Curr Drug Targets. 2024;25(6):404-415. doi: 10.2174/0113894501290512240327091531. Curr Drug Targets. 2024. PMID: 38566380 Review.
References
-
- Fine J‐D, Bauer E A, Gedde‐Dahl T., Jr Inherited epidermolysis bullosa: definition and historical overview. In: Fine J‐D, Bauer EA, McGuire J, Moshell A, eds. Epidermolysis bullosa: clinical, epidemiologic, and laboratory advances and the findings of the National Epidermolysis Bullosa Registry. Baltimore, MD: The Johns Hopkins University Press, 19991–19.
-
- Uitto J, Richard G. Progress in epidermolysis bullosa: from eponyms to molecular genetic classification. Clin Dermatol 20052333–40. - PubMed
-
- Anton‐Lamprecht I, Gedde‐Dahl T. Epidermolysis bullosa. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR, eds. Principles and practice of medical genetics. 4th ed. London: Churchill‐Livingston, 20023810–3897.
-
- Fine J‐D, Eady R A J, Bauer E A, Briggaman R A, Bruckner‐Tuderman L, Christiano A, Heagerty A, Hintner H, Jonkman M F, McGrath J, McGuire J, Moshell A, Shimizu H, Tadini G, Uitto J. Revised classification system for inherited epidermolysis bullosa: report of the second international consensus meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol 2000421051–1066. - PubMed
-
- Pulkkinen L, Uitto J. Hemidesmosomal variants of epidermolysis bullosa: Mutations in the α6β4 integrin and the 180‐kD bullous pemphigoid antigen/type XVII collagen genes. Exp Dermatol 1998746–64. - PubMed